Stryker
Stryker Corporation is a major American medical technology manufacturer that designs, produces, and markets advanced medical devices and equipment for global healthcare providers. The company operates through two main reporting segments, MedSurg and Neurotechnology, alongside its extensive Orthopaedics product business segment. Key product lines include reconstructive joint implants, surgical navigation systems, endoscopic equipment, neurosurgical devices, and Mako robotic-arm assisted surgery technology. Revenue is primarily generated through direct product sales, capital equipment leases, and long-term service agreements with hospitals, surgical centers, and outpatient facilities. Principal end markets comprise orthopedic surgeons, neurosurgeons, emergency responders, and hospital network procurement departments across North America, Europe, and Asia-Pacific. As a worldwide market leader in orthopedic hip and knee replacement implants, the corporation maintains a dominant position in advanced surgical automation. Headquartered in Kalamazoo, Michigan, Stryker Corporation is publicly listed on the New York Stock Exchange under the ticker symbol SYK.
86 of the funds FundTelligence covers report a position in Stryker.
- Legal name
- STRYKER CORP
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 86
- Exposure themes
- Healthcare, Orthopaedic & Spine Robotics, Robotics & Automation, Ageing & Longevity, Healthy Ageing & Function, Mobility & Orthopaedics
Funds holding Stryker
- Fondita Healthcare — Fondita · 3.59 % (largest positions only, October 2026)
- HealthInvest Sustainable Healthcare — HealthInvest · 2.5 % (partially disclosed portfolio, September 2026)
- Nordea PM Globale Aktier Fokus — Nordea Funds · 2.45 % (full portfolio disclosed, September 2026)
- Nordea Global Portfolio Fund — Nordea Funds · 2.42 % (full portfolio disclosed, September 2026)
- AB Global Core Equity Portfolio — AllianceBernstein · 2.35 % (largest positions only, September 2026)
- SEB Läkemedelsfond — SEB · 2.31 % (full portfolio disclosed, June 2026)
- Schroder ISF Healthcare Innovation — Schroders · 2.26 % (full portfolio disclosed, June 2026)
- JPM Global Healthcare Fund — JPM · 2.2 % (full portfolio disclosed, June 2026)
Showing the 8 largest of 86 funds holding it.